This inventor holds 1 USPTO granted patent and 3 published patent applications and 2 EPO patents. Top assignee: Pohang University of Science and Technology Foundation. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: **Innovations in Angiogenesis: The Achievements of Inventor Wan-Uk Kim**
Introduction
Wan-Uk Kim, an inventor based in Suwon-si, South Korea, has made significant contributions to the field of pharmaceuticals with his innovative research. He holds a patent that focuses on the role of connective tissue growth factor in angiogenesis, a vital process for tissue regeneration and repair.
Latest Patents
Kim's notable patent is titled "Pharmaceutical composition using connective-tissue growth factor." This patent encompasses a pharmaceutical composition aimed at promoting angiogenesis through the use of connective tissue growth factor (CTGF). The invention describes a method for enhancing angiogenesis by utilizing either the connective tissue growth factor itself or compositions that inhibit angiogenesis, which include various polypeptides, antibodies, or compounds that bind to CTGF. This research highlights a fragment of the CTGF protein that plays a crucial role in activating cellular mechanisms and induces specific signaling pathways essential for angiogenesis.
Career Highlights
Wan-Uk Kim is affiliated with the Postech Academy-Industry Foundation, where he has been able to leverage his expertise in pharmaceutical innovations. His work centers on the therapeutic applications of connective tissue growth factor, which can potentially revolutionize treatments for conditions that require enhanced blood vessel formation.
Collaborations
Throughout his career, Kim has collaborated with esteemed colleagues such as Sung Ho Ryu and Pann-Ghill Suh. Their joint efforts in research offer valuable insights and advancements in the pharmaceutical domain, especially in addressing challenges related to angiogenesis.
Conclusion
With a strong focus on innovative therapeutic solutions, Wan-Uk Kim stands out as a key figure in the research and development of angiogenesis-related pharmaceutical compositions. His contributions, particularly in relation to connective tissue growth factor, promise to open new avenues for effective treatments in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile